Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.6400 (5.25%) ($12.7100 - $13.8500) on Tue. Aug. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.38% (three month average) | RSI | 58 | Latest Price | $13.6400(5.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.69% in a week (0% probabilities). VIXM(-32%) VXX(-27%) UNG(-11%) UUP(-8%) TLT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.69% (StdDev 5.38%) | Hourly BBV | 0 () | Intraday Trend | 5.4% | | | |
|
5 Day Moving Average | $13.07(4.36%) | 10 Day Moving Average | $12.72(7.23%) | 20 Day Moving Average | $12.7(7.4%) | To recent high | -12% | To recent low | 52.6% | Market Cap | $1.014b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |